Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
NOX4 was originally discovered as a kidney-specific NOX. NOX4 is expressed in different organelles, such as mitochondria, nuclei, and endoplasmic reticulum. Later, it was found that NOX4 is expressed in large amounts in the cardiovascular system, especially in endothelial cells and vascular smooth muscle cells. NOX4 is the most expressed NOX. In general, NOX4 activity is mainly regulated at the transcription level. In the cardiovascular system, stimulation of G protein-coupled receptor activators, growth factors, cytokines, oxidized low-density lipoprotein, and hypoxia-reoxygenation can activate NOX4.
Figure 1. The role of NOX4 in angiogenesis. (Chen, C., et al. 2017)
The Role of NOX4
NOX4 plays an important role in a variety of cells. In cardiomyocytes and vascular smooth muscle cells, NOX4 activates the transcription factor NF-E2 related factor 2 (Nrf2) signaling pathway to regulate the antioxidant stress response. In endothelial cells, it activates endothelial nitric oxide synthase by activating the control gene transcriptional kinase/extracellular regulated protein kinase pathway, thereby promoting vascular cell survival. In endothelial cells under ischemic and inflammatory stress, NOX4 deficiency can attenuate the expression of the protein heme oxygenase-1 associated with inflammation and cell death. This dual effect of NOX4 is likely to depend on the level, duration, and subcellular localization of ROS under stress conditions. The activation of NOX4 is the main source of ROS in blood vessels, and the expression of NOX4 is mainly reflected in the level of ROS changes. Because ROS has the ability to target oxidative molecules, it can regulate molecular pathways, for example, to control protein activity through post-transcriptional translation modifications. Under cellular stress, oxidative stress regulates autophagy.
NOX4 and Atherosclerosis
NOX4 plays an important role in atherosclerosis as an endogenous anti-atherosclerotic enzyme that produces H2O2. Schürmann et al. hybridized NOX4-/-mice with ApoE-/-mice to construct a partial carotid artery ligation model and fed them on conventional foods and high-fat diets, respectively. The results showed that H2O2 production in the aortic ring of NOX4 and apolipoprotein E double knockout mice was lower than that of wild type mice. In addition, NOX4 deficiency can increase atherosclerosis, resulting in a significantly smaller carotid lumen than wild-type mice, and NOX4 deficiency in endothelial cells results in increased leukocyte adhesion. Therefore, NOX4 prevents vascular inflammation by limiting the angiogenesis of leukocytes, and ultimately weakens the development of atherosclerosis. Similar studies have demonstrated that NOX4 and apolipoprotein E double knockout animals appear to prevent the progression of atherosclerosis. Therefore, the current research proves that NOX4 has a beneficial effect on atherosclerosis.
NOX4 and Hypertension
The mechanism of essential hypertension is not fully understood, but many studies have shown the important role of NOX4 in the pathogenesis of hypertension. In the study of NOX4 and hypertension, to test whether the NOX4 enzyme affects angiotensin II-related hypertension, the researchers monitored systolic and diastolic arterial pressure in mice infused with angiotensin II wild-type and NOX4-inhibited. Angiotensin Ⅱ-induced pulse pressure was found to increase after blocking NOX4. In the angiotensin Ⅱ-induced mouse hypertension model, it was confirmed that down-regulation of NOX4 expression in the aorta can increase inflammation and endothelial dysfunction. Studies have also reported that NOX4 knockout mice develop pulmonary hypertension and endothelial dysfunction. Lu et al. exposed male SD rats to chronic intermittent hypoxia (CIH) for 21 days. It was found that compared to the blood pressure of the control group, the blood pressure of CIH rats began to increase 2 weeks after the start of the experiment, and then stabilized at a high level at the end of the 3rd week. Cysteine-treated rats attenuated this response, demonstrating that CIH-induced increase in blood pressure is mediated in part by NOX4-induced ROS production. By knocking out the NOX4 gene in salt-sensitive hypertension, the salt-sensitive rat model has a reduced blood pressure response to high salt. The above experiments have proved that in hypertension, NOX4 has a regulatory effect from different mechanisms and pathways.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.